Steven Sanislo

Publication Details

  • Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.

    Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR, Blumenkranz MS. Retina. 2008; 28 (8): 1151-8

    To systematically study potential adverse events associated with the use of intraocular bevacizumab at a single medical center.

    PubMedID: 18685542

Stanford Medicine Resources:

Footer Links: